Furthermore, even below this diagnostic threshold, elevated CTPC levels (e.g., ≥0.01–0.1% by MFC/NGF) have consistently been associated with adverse outcomes in newly diagnosed MM. Here, NGF is linked to Miyoshi myopathy.